Gabon vs Senegal: Tuberculosis patients living with HIV receiving antiretroviral therapy
Gabon
472 patients
in 2021
Senegal
494 patients
in 2021
Gabon rank
52nd
Senegal rank
50th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Gabon
- Senegal
How they compare
Senegal currently reports 494 patients against 472 patients in Gabon, a difference of 22 patients.
The two have swapped places 3 times across 13 shared years of data; in 2008 it was Gabon ahead.
Gabon ranks 52nd and Senegal ranks 50th of 183 countries.
Across the 3 decades both report, Gabon averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Gabon | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 325.5 patients | 164.5 patients | 161 patients | Gabon |
| 2010s | 472.44 patients | 602.56 patients | 130.11 patients | Senegal |
| 2020s | 271.5 patients | 540.5 patients | 269 patients | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Gabon or Senegal?
- Senegal, at 494 patients against 472 patients in Gabon as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Gabon and Senegal?
- 22 patients, with Senegal ahead.
- How many years of comparable data are there for Gabon and Senegal?
- 13 years are reported by both, from 2008 to 2021.
- How do Gabon and Senegal rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Gabon ranks 52nd and Senegal ranks 50th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.